Investment Thesis
Bruker demonstrates solid revenue growth and healthy gross margins (45.9%), but is currently unprofitable with negative net income and concerning operating leverage issues. The company generates positive free cash flow (43.3M) and maintains reasonable liquidity, though weak interest coverage (1.4x) and high debt levels warrant caution on near-term financial flexibility.
Strengths
- Strong gross margin of 45.9% indicates pricing power and operational efficiency in core business
- Positive free cash flow generation of 43.3M despite net losses shows underlying cash generation ability
- Solid current ratio of 1.73x provides adequate short-term liquidity cushion
- Modest revenue growth of 2.1% YoY in a capital-intensive analytical instruments sector
Risks
- Currently unprofitable with negative net margin (-0.3%) and negative ROE (-0.4%), indicating operational challenges
- Weak interest coverage ratio of 1.4x with 1.9B in long-term debt creates refinancing and financial distress risk
- Operating margin severely compressed at 2.0% despite 45.9% gross margins, suggesting SG&A and operational inefficiencies
- Low quick ratio of 0.87x indicates potential liquidity stress if current liabilities accelerate
- Significant 16 Form 4 insider filings in last 90 days warrant monitoring for insider sentiment
Key Metrics to Watch
- Operating margin improvement trajectory and SG&A expense control
- Net income return to profitability and sustainability of positive FCF
- Debt reduction progress and interest coverage ratio stabilization above 2.0x
- Gross margin sustainability amid potential pricing pressure or product mix shifts
Financial Metrics
Revenue
3.4B
Net Income
-8.6M
EPS (Diluted)
$-0.15
Free Cash Flow
43.3M
Total Assets
6.2B
Cash
298.8M
Profitability Ratios
Gross Margin
45.9%
Operating Margin
2.0%
Net Margin
-0.3%
ROE
-0.4%
ROA
-0.1%
FCF Margin
1.3%
Balance Sheet & Liquidity
Current Ratio
1.73x
Quick Ratio
0.87x
Debt/Equity
0.76x
Debt/Assets
59.8%
Interest Coverage
1.42x
Long-term Debt
1.9B
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-03-21T12:02:11.465215 |
Data as of: 2025-12-31 |
Powered by Claude AI